Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 673815, 7 pages
http://dx.doi.org/10.1155/2015/673815
Research Article

Significant Depletion of CD4+ T Cells Occurs in the Oral Mucosa during Simian Immunodeficiency Virus Infection with the Infected CD4+ T Cell Reservoir Continuing to Persist in the Oral Mucosa during Antiretroviral Therapy

1Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA
2Bioqual Inc., Rockville, MD 20850, USA

Received 11 January 2015; Accepted 7 April 2015

Academic Editor: Clelia M. Riera

Copyright © 2015 Jeffy George et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Chattopadhyay, D. J. Caplan, G. D. Slade, D. C. Shugars, H.-C. Tien, and L. L. Patton, “Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults,” Community Dentistry and Oral Epidemiology, vol. 33, no. 1, pp. 35–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Greenspan and J. S. Greenspan, “Oral manifestations of HIV infection,” AIDS Clinical Care, vol. 9, no. 4, pp. 29–33, 1997. View at Google Scholar · View at Scopus
  3. I. D. Miziara and R. Weber, “Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients,” Oral Diseases, vol. 12, no. 4, pp. 402–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. L. Patton, “Oral lesions associated with human immunodeficiency virus disease,” Dental Clinics of North America, vol. 57, no. 4, pp. 673–698, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. L. Patton and C. van der Horst, “Oral infections and other manifestations of HIV disease,” Infectious Disease Clinics of North America, vol. 13, no. 4, pp. 879–900, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Ramírez-Amador, S. Ponce-De-León, J. Sierra-Madero, L. Soto-Ramírez, L. Esquivel-Pedraza, and G. Anaya-Saavedra, “Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients,” AIDS Research and Human Retroviruses, vol. 21, no. 12, pp. 981–990, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. Reichart, “Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma,” Medical Microbiology and Immunology, vol. 192, no. 3, pp. 165–169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Reznik, “Oral manifestations of HIV disease,” Topics in HIV Medicine, vol. 13, no. 5, pp. 143–148, 2005. View at Google Scholar · View at Scopus
  9. J. M. Brenchley, T. W. Schacker, L. E. Ruff et al., “CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract,” The Journal of Experimental Medicine, vol. 200, no. 6, pp. 749–759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kader, W. M. Hassan, M. Eberly et al., “Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection,” Journal of Virology, vol. 82, no. 22, pp. 11467–11471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kader, X. Wang, M. Piatak et al., “α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection,” Mucosal Immunology, vol. 2, no. 5, pp. 439–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer, “Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection,” Nature, vol. 434, no. 7037, pp. 1093–1097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Mehandru, M. A. Poles, K. Tenner-Racz et al., “Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 761–770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. S. Veazey, M. DeMaria, L. V. Chalifoux et al., “Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection,” Science, vol. 280, no. 5362, pp. 427–431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. Allen, “Animal models of oral candidiasis. A review,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 78, no. 2, pp. 216–221, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. H. Samaranayake and L. P. Samaranayake, “Experimental oral candidiasis in animal models,” Clinical Microbiology Reviews, vol. 14, no. 2, pp. 398–429, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Wang, “Nonhuman primate models for Epstein-Barr virus infection,” Current Opinion in Virology, vol. 3, no. 3, pp. 233–237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kader, S. Bixler, M. Piatak, J. Lifson, and J. J. Mattapallil, “The epidemiology of vulvovaginal candidiasis: risk factors,” Journal of Medical Primatology, vol. 38, no. 1, pp. 32–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. N. Cline, J. W. Bess, M. Piatak Jr., and J. D. Lifson, “Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS,” Journal of Medical Primatology, vol. 34, no. 5-6, pp. 303–312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Bixler, N. G. Sandler, D. C. Douek, and J. J. Mattapallil, “Suppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection,” Journal of Virology, vol. 87, no. 12, pp. 7093–7101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Eberly, M. Kader, W. Hassan et al., “Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection,” The Journal of Immunology, vol. 182, no. 3, pp. 1439–1448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kader, S. Bixler, M. Roederer, R. Veazey, and J. J. Mattapallil, “CD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on alpha4bet7 receptor expression during acute SIV infection,” Journal of Medical Primatology, vol. 38, supplement 1, pp. 24–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. D. Lifson, J. L. Rossio, M. Piatak Jr. et al., “Role of CD8+ lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment,” Journal of Virology, vol. 75, no. 21, pp. 10187–10199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Guadalupe, E. Reay, S. Sankaran et al., “Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy,” Journal of Virology, vol. 77, no. 21, pp. 11708–11717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Li, L. Dua, J. D. Estes et al., “Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells,” Nature, vol. 434, no. 7037, pp. 1148–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. J. Pitcher, S. I. Hagen, J. M. Walker et al., “Development and homeostasis of T cell memory in rhesus macaque,” The Journal of Immunology, vol. 168, no. 1, pp. 29–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Bixler and J. J. Mattapallil, “Loss and dysregulation of Th17 cells during HIV infection,” Clinical and Developmental Immunology, vol. 2013, Article ID 852418, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. B. Anthony, C. Yoder, J. A. Metcalf et al., “Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 2, pp. 125–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Belmonte, M. Olmos, A. Fanin et al., “The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART,” AIDS, vol. 21, no. 15, pp. 2106–2108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. T.-W. Chun, D. C. Nickle, J. S. Justement et al., “Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy,” Journal of Infectious Diseases, vol. 197, no. 5, pp. 714–720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Finzi, M. Hermankova, T. Pierson et al., “Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy,” Science, vol. 278, no. 5341, pp. 1295–1300, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Mehandru, M. A. Poles, K. Tenner-Racz et al., “Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection,” PLoS Medicine, vol. 3, no. 12, article e484, 2006. View at Publisher · View at Google Scholar
  33. M. Macal, S. Sankaran, T.-W. Chun et al., “Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses,” Mucosal Immunology, vol. 1, no. 6, pp. 475–488, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. N. R. Klatt and J. M. Brenchley, “Th17 cell dynamics in HIV infection,” Current Opinion in HIV and AIDS, vol. 5, no. 2, pp. 135–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Brenchley, M. Paiardini, K. S. Knox et al., “Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections,” Blood, vol. 112, no. 7, pp. 2826–2835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. N. R. Klatt, N. T. Funderburg, and J. M. Brenchley, “Microbial translocation, immune activation, and HIV disease,” Trends in Microbiology, vol. 21, no. 1, pp. 6–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. C. Moore, S. L. Bixler, M. G. Lewis, D. Verthelyi, and J. J. Mattapallil, “Mucosal and peripheral Lin- HLA-DR+ CD11c/123- CD13+ CD14- mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection,” Journal of Virology, vol. 86, no. 2, pp. 1069–1078, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. T.-W. Chun, L. Stuyver, S. B. Mizell et al., “Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 24, pp. 13193–13197, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Poles, W. J. Boscardin, J. Elliott et al., “Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 1, pp. 65–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. E. Sharkey, I. Teo, T. Greenough et al., “Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy,” Nature Medicine, vol. 6, no. 1, pp. 76–81, 2000. View at Publisher · View at Google Scholar · View at Scopus